Works by Myung-Ju Ahn

Results: 221
    1
    2
    3
    4
    5
    6
    7
    8

    STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 274, doi. 10.1016/j.cllc.2023.12.010
    By:
    • Rodriguez-Abreu, Delvys;
    • Bosch-Barrera, Joaquim;
    • Gray, Jhanelle E.;
    • Myung-Ju Ahn;
    • Johnson, Melissa;
    • Xinwei Yu;
    • Mohammad, Saad;
    • Xueying Chen;
    • Todd, Trever;
    • Jongseok Kim;
    • Reck, Martin
    Publication type:
    Article
    9

    Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 8, p. 670, doi. 10.1016/j.cllc.2022.07.012
    By:
    • Myung-Ju Ahn;
    • Mendoza, Marvin Jonne L.;
    • Pavlakis, Nick;
    • Terufumi Kato;
    • Soo, Ross A.;
    • Dong-Wan Kim;
    • Chong Kin Liam;
    • Te-Chun Hsia;
    • Chee Khoon Lee;
    • Thanyanan Reungwetwattana;
    • Sarayut Geater;
    • Siu Hong Chan, Oscar;
    • Naiyarat Prasongsook;
    • Solomon, Benjamin J.;
    • Thi Thai Hoa Nguyen;
    • Toshiyuki Kozuki;
    • Chih-Hsin Yang, James;
    • Yi-Long Wu;
    • Shu Kam Mok, Tony;
    • Shao-Weng Tan, Daniel
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17

    ctDNA Dynamics, Prognostic Markers, and Mechanisms of Resistance in Tepotinib-treated MET exon 14 (METex14) Skipping NSCLC in the VISION Trial.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 352
    By:
    • Xiuning Le;
    • Garassino, Marina Chiara;
    • Myung-Ju Ahn;
    • Felip, Enriqueta;
    • Cortot, Alexis B.;
    • Hiroshi Sakai;
    • Mazières, Julien;
    • Thomas, Michael;
    • Viteri, Santiago;
    • Conte, Pierfranco;
    • Chih-Hsin Yang, James;
    • Iams, Wade Thomas;
    • Griesinger, Frank;
    • Braggio, Danielle;
    • Stroh, Christopher;
    • Juraeva, Dilafruz;
    • Wang, Danyi;
    • Johne, Andreas;
    • Paik, Paul K.
    Publication type:
    Article
    18

    Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.

    Published in:
    Lung Cancer: Targets & Therapy, 2024, v. 15, p. 87, doi. 10.2147/LCTT.S463429
    By:
    • Ou, Sai-Hong Ignatius;
    • Le, Xiuning;
    • Nagasaka, Misako;
    • Reungwetwattana, Thanyanan;
    • Ahn, Myung-Ju;
    • Lim, Darren WT;
    • Santos, Edgardo S;
    • Shum, Elaine;
    • Lau, Sally CM;
    • Lee, Jii Bum;
    • Calles, Antonio;
    • Wu, Fengying;
    • Lopes, Gilberto;
    • Sriuranpong, Virote;
    • Tanizaki, Junko;
    • Horinouchi, Hidehito;
    • Garassino, Marina C;
    • Popat, Sanjay;
    • Besse, Benjamin;
    • Rosell, Rafael
    Publication type:
    Article
    19

    The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.

    Published in:
    Cancer Research & Treatment, 2025, v. 57, n. 1, p. 39, doi. 10.4143/crt.2024.421
    By:
    • Kim, Bum Jun;
    • Maeng, Chi Hoon;
    • Keam, Bhumsuk;
    • Im, Young-Hyuck;
    • Ro, Jungsil;
    • Jung, Kyung Hae;
    • Im, Seock-Ah;
    • Kim, Tae Won;
    • Lee, Jae Lyun;
    • Heo, Dae Seog;
    • Kim, Sang-We;
    • Park, Keunchil;
    • Ahn, Myung-Ju;
    • Cho, Byoung Chul;
    • Kim, Hoon-Kyo;
    • Kang, Yoon-Koo;
    • Cho, Jae Yong;
    • Yun, Hwan Jung;
    • Nam, Byung-Ho;
    • Zang, Dae Young
    Publication type:
    Article
    20

    Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.

    Published in:
    Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1084, doi. 10.4143/crt.2024.084
    By:
    • Shin, Junghoon;
    • Park, Sehhoon;
    • Kim, Kyung Hwan;
    • Shin, Eui-Cheol;
    • Jung, Hyun Ae;
    • Cho, Jong Ho;
    • Sun, Jong-Mu;
    • Lee, Se-Hoon;
    • Choi, Yong Soo;
    • Ahn, Jin Seok;
    • Kim, Jhingook;
    • Park, Keunchil;
    • Shim, Young Mog;
    • Kim, Hong Kwan;
    • Noh, Jae Myoung;
    • Ahn, Yong Chan;
    • Pyo, Hongryull;
    • Ahn, Myung-Ju
    Publication type:
    Article
    21

    Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials.

    Published in:
    Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1068, doi. 10.4143/crt.2024.008
    By:
    • Kim, Youjin;
    • Keam, Bhumsuk;
    • Kang, Eun Joo;
    • Kim, Jin-Soo;
    • Kim, Hye Ryun;
    • Lee, Keun-Wook;
    • Kwon, Jung Hye;
    • Lee, Kyoung Eun;
    • Yang, Yaewon;
    • Choi, Yoon Hee;
    • Kim, Min Kyoung;
    • Ji, Jun Ho;
    • Yun, Tak;
    • Choi, Moon Young;
    • Lee, Ki Hyeong;
    • Kim, Sung-Bae;
    • Ahn, Myung-Ju
    Publication type:
    Article
    22
    23
    24

    Lazertinib versus Gefitinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.

    Published in:
    Cancer Research & Treatment, 2024, v. 56, n. 1, p. 48, doi. 10.4143/crt.2023.453
    By:
    • Ki Hyeong Lee;
    • Byoung Chul Cho;
    • Myung-Ju Ahn;
    • Yun-Gyoo Lee;
    • Youngjoo Lee;
    • Jong-Seok Lee;
    • Joo-Hang Kim;
    • Young Joo Min;
    • Gyeong-Won Lee;
    • Sung Sook Lee;
    • Kyung-Hee Lee;
    • Yoon Ho Ko;
    • Byoung Yong Shim;
    • Sang-We Kim;
    • Sang Won Shin;
    • Jin-Hyuk Choi;
    • Dong-Wan Kim;
    • Eun Kyung Cho;
    • Keon Uk Park;
    • Jin-Soo Kim
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea.

    Published in:
    Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1112, doi. 10.4143/crt.2020.245
    By:
    • Sun Min Lim;
    • Sang-We Kim;
    • Byoung Chul Cho;
    • Jin Hyung Kang;
    • Myung-Ju Ahn;
    • Dong-Wan Kim;
    • Young-Chul Kim;
    • Jin Soo Lee;
    • Jong-Seok Lee;
    • Sung Yong Lee;
    • Keon Uk Park;
    • Ho Jung An;
    • Eun Kyung Cho;
    • Tae Won Jang;
    • Bong-Seog Kim;
    • Joo-Hang Kim;
    • Sung Sook Lee;
    • Im-II Na;
    • Seung Soo Yoo;
    • Ki Hyeong Lee
    Publication type:
    Article
    37
    38
    39
    40
    41
    42

    Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.

    Published in:
    Cancer Research & Treatment, 2019, v. 51, n. 1, p. 300, doi. 10.4143/crt.2018.012
    By:
    • Sun Min Lim;
    • Sang Hee Cho;
    • In Gyu Hwang;
    • Jae Woo Choi;
    • Hyun Chang;
    • Myung-Ju Ahn;
    • Keon Uk Park;
    • Ji-Won Kim;
    • Yoon Ho Ko;
    • Hee Kyung Ahn;
    • Byoung Chul Cho;
    • Byung-Ho Nam;
    • Sang Hoon Chun;
    • Ji Hyung Hong;
    • Jung Hye Kwon;
    • Jong Gwon Choi;
    • Eun Joo Kang;
    • Tak Yun;
    • Keun-Wook Lee;
    • Joo-Hang Kim
    Publication type:
    Article
    43
    44
    45

    Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 4, p. 937, doi. 10.4143/crt.2016.423
    By:
    • Keunchil Park;
    • Eun Kyung Cho;
    • Maximino Bello;
    • Myung-Ju Ahn;
    • Thongprasert, Sumitra;
    • Eun-Kee Song;
    • Soldatenkova, Victoria;
    • Depenbrock, Henrik;
    • Puri, Tarun;
    • Orlando, Mauro
    Publication type:
    Article
    46
    47
    48

    Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 2, p. 458, doi. 10.4143/crt.2015.135
    By:
    • Jin Hyoung Kang;
    • Myung-Ju Ahn;
    • Dong-Wan Kim;
    • Eun Kyung Cho;
    • Joo-Hang Kim;
    • Sang Won Shin;
    • Xin Wang;
    • Jong Seok Kim;
    • Mauro Orlando;
    • Keunchil Park
    Publication type:
    Article
    49
    50